Alectinib M4 metabolite D4
| Product Name | Alectinib M4 metabolite D4 |
|---|---|
| Alternate Names | Alectinib Stable Isotopes, Stable Isotopes of Alectinib |
| CAT No. | CS-O-32642 |
| CAS No. | 1256585-04-2 (Unlabeled) |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | 460.6 g/mol |
| Mol. For. | C28H28D4N4O2 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Alectinib |
| Therapeutic | Anti-Cancer / Oncology |
| Canonical Smiles | CCC1=CC2=C(C=C1N3CCC(CC3)NCCO)C(C4=C(C2=O)C5=C(N4)C=C(C=C5)C#N)(C)C |
| InchIKey | XNKBNGIKXNABDO-UHFFFAOYSA-N |
| Inchl | InChI=1S/C28H32N4O2/c1-4-18-14-21-22(15-24(18)32-10-7-19(8-11-32)30-9-12-33)28(2,3)27-25(26(21)34)20-6-5-17(16-29)13-23(20)31-27/h5-6,13-15,19,30-31,33H,4,7-12H2,1-3H3 |
| IUPAC | 9-ethyl-8-[4-(2-hydroxyethylamino)piperidin-1-yl]-6,6-dimethyl-11-oxo-5H-benzo[b]carbazole-3-carbonitrile |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Alectinib M4 metabolite D4 is a chemical compound that is produced as a metabolite of Alectinib, a medication used for the treatment of advanced non-small cell lung cancer. Alectinib M4 metabolite D4 is an active metabolite of Alectinib and has similar pharmacological effects.
Alectinib M4 metabolite D4 is a potent inhibitor of the anaplastic lymphoma kinase (ALK) and the c-ros oncogene 1 (ROS1). These proteins are known to promote the growth and spread of cancer cells in the body. By inhibiting these proteins, Alectinib M4 metabolite D4 slows down the growth and spread of cancer cells, thereby helping to manage cancer.
Alectinib M4 metabolite D4 is usually administered orally, and its dosage is determined by a healthcare professional based on the patient's medical condition and response to treatment. The medication is available in capsule form, and it is important to follow the prescribed dosage and duration of treatment.
Like all medications, Alectinib M4 metabolite D4 has potential side effects. Some of the common side effects include fatigue, nausea, vomiting, diarrhea, and constipation. Patients undergoing treatment with Alectinib M4 metabolite D4 should be monitored closely by a healthcare professional for any adverse effects or allergic reactions.
In conclusion, Alectinib M4 metabolite D4 is an important medication used in the management of advanced non-small cell lung cancer. Its potent inhibitory effects on ALK and ROS1 make it a valuable treatment option for patients with this condition.
Get an Instant Quote
Related Compounds
Alectinib D8 | Alectinib D6 | Alectinib D5 |